Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2015

Open Access 01-12-2015 | Research article

The care needs of patients with idiopathic pulmonary fibrosis and their carers (CaNoPy): results of a qualitative study

Authors: Cathy Sampson, Ben Hope Gill, Nicholas Kim Harrison, Annmarie Nelson, Anthony Byrne

Published in: BMC Pulmonary Medicine | Issue 1/2015

Login to get access

Abstract

Background

Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrotic interstitial lung disease of unknown origin. It has a median survival of three years but a wide range in survival rate which is difficult to predict at the time of diagnosis. Specialist guidance promotes a patient centred approach emphasising regular assessment, information giving and supportive care coordinated by a multidisciplinary team (MDT). However understanding of patient and carer experience across the disease trajectory is limited and detailed guidance for MDTs on communication, assessment, and triggers for supportive and palliative interventions is lacking. This study addresses uncertainties relating to care needs of patients and carers at different stages of the IPF disease trajectory.

Methods

Following ethical approval a multi-centre mixed-methods study recruited participants with IPF at four stages of the disease trajectory. Qualitative analysis was used to analyse 48 semi-structured interviews with patients (27) and paired carers (21).

Results

Patients and carers outlined key elements of MDT activity capable of having significant impact on the care experience. These were structured around:
  • Focus of clinical encounters
  • Timely identification of changes in health status and functional activity
  • Understanding of symptoms and medical interventions
  • Coping strategies and carer roles.

Conclusions

Patients diagnosed with IPF have a clear understanding of their prognosis but little understanding of how their disease will progress and how it will be managed. In depth analysis of the experiences of patients and carers offers guidance for refining IPF clinical pathways. This will support patients and carers at key transition points in line with National Institute for Health and Care Excellence (NICE) guidance.
Appendix
Available only for authorised users
Literature
1.
go back to reference Verma S, Slutsky A. Idiopathic Pulmonary Fibrosis - New Insights. N Engl J Med. 2007;356(13):1370–2.CrossRefPubMed Verma S, Slutsky A. Idiopathic Pulmonary Fibrosis - New Insights. N Engl J Med. 2007;356(13):1370–2.CrossRefPubMed
2.
go back to reference Navaratnam V, Fogarty A, Glendening R, McKeever T, Hubbard R. The increasing secondary care burden of idiopathic pulmonary fibrosis: hospital admission trends from 1998 to 2010. Chest. 2013;143(4):1078–84.CrossRefPubMed Navaratnam V, Fogarty A, Glendening R, McKeever T, Hubbard R. The increasing secondary care burden of idiopathic pulmonary fibrosis: hospital admission trends from 1998 to 2010. Chest. 2013;143(4):1078–84.CrossRefPubMed
3.
go back to reference Hubbard R, Johnston I, Britton J. Survival in Patients with Cryptogenic Fibrosing Alveolitis. Chest. 1998;113(2):396–400.CrossRefPubMed Hubbard R, Johnston I, Britton J. Survival in Patients with Cryptogenic Fibrosing Alveolitis. Chest. 1998;113(2):396–400.CrossRefPubMed
4.
go back to reference Ley B, Collard H. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol. 2013;11/25(5):483–92.CrossRef Ley B, Collard H. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol. 2013;11/25(5):483–92.CrossRef
5.
go back to reference Swigris J, Stewart A, Gould M, Wilson S. Patients’ perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes. 2005;3:61–9.PubMedCentralCrossRefPubMed Swigris J, Stewart A, Gould M, Wilson S. Patients’ perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes. 2005;3:61–9.PubMedCentralCrossRefPubMed
6.
go back to reference Tomioka H, Imanaka K, Hashimoto K, Iwasaki H. Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis--Cross-Sectional and Longitudinal Study. Intern Med. 2007;46:1533–42.CrossRefPubMed Tomioka H, Imanaka K, Hashimoto K, Iwasaki H. Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis--Cross-Sectional and Longitudinal Study. Intern Med. 2007;46:1533–42.CrossRefPubMed
7.
go back to reference Collard H, Ward A, Lanes S, Cortney Hayflinger D, Rosenberg D, Hunsche E. Burden of illness in idiopathic pulmonary fibrosis. J Med Econ. 2012;15(5):829–35.CrossRefPubMed Collard H, Ward A, Lanes S, Cortney Hayflinger D, Rosenberg D, Hunsche E. Burden of illness in idiopathic pulmonary fibrosis. J Med Econ. 2012;15(5):829–35.CrossRefPubMed
8.
go back to reference Bajwah S, Ross J, Peacock J, Higginson I, Wells A, Patel A, et al. Interventions to Improve Symptoms and Quality of Life of Patients with Fibrotic Interstitial Lung Disease: A Systematic Review of the Literature. Thorax. 2013;68:867–79.CrossRefPubMed Bajwah S, Ross J, Peacock J, Higginson I, Wells A, Patel A, et al. Interventions to Improve Symptoms and Quality of Life of Patients with Fibrotic Interstitial Lung Disease: A Systematic Review of the Literature. Thorax. 2013;68:867–79.CrossRefPubMed
9.
go back to reference Saketkoo L, Mittoo S, Huscher D, Khanna D, Delaripa P, Distler O, et al. Connective Tissue Disease Related Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: Provisional Core Sets of Domains and Instruments for Use in Clinical Trials. Thorax. 2014;69:436–44.PubMedCentralCrossRef Saketkoo L, Mittoo S, Huscher D, Khanna D, Delaripa P, Distler O, et al. Connective Tissue Disease Related Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: Provisional Core Sets of Domains and Instruments for Use in Clinical Trials. Thorax. 2014;69:436–44.PubMedCentralCrossRef
11.
go back to reference Raghu G, Collard H, Egan J, Martinez F, Behr J, Brown K, et al. An Official Ats/Ers/Jrs/Alat Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med. 2011;183(6):788–824.CrossRefPubMed Raghu G, Collard H, Egan J, Martinez F, Behr J, Brown K, et al. An Official Ats/Ers/Jrs/Alat Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med. 2011;183(6):788–824.CrossRefPubMed
12.
go back to reference Lee J, McLaughlin S, Collard H. Comprehensive Care of the Patient with Idiopathic Pulmonary Fibrosis. Curr Opin Pulm Med. 2011;17:348–54.CrossRefPubMed Lee J, McLaughlin S, Collard H. Comprehensive Care of the Patient with Idiopathic Pulmonary Fibrosis. Curr Opin Pulm Med. 2011;17:348–54.CrossRefPubMed
13.
go back to reference Smith J, Flowers P, Larkin M. Interpretative Phenomenological Analysis: Theory, Method and Research. London: Sage; 2009. Smith J, Flowers P, Larkin M. Interpretative Phenomenological Analysis: Theory, Method and Research. London: Sage; 2009.
15.
go back to reference Berg B, Lune H. Qualitative Research Methods for the Social Sciences. 8th Ed. 2011;Essex: Pearson. Berg B, Lune H. Qualitative Research Methods for the Social Sciences. 8th Ed. 2011;Essex: Pearson.
16.
go back to reference Pope C, Mays N. Qualitative Research in Healthcare 3rd Ed. London: Wiley-Blackwell; 2006. Pope C, Mays N. Qualitative Research in Healthcare 3rd Ed. London: Wiley-Blackwell; 2006.
17.
go back to reference Swigris J, Kuschner W, Kelsey J, Gould M. Idiopathic Pulmonary Fibrosis: Challenges and Opportunities for the Clinician and Investigator. Chest. 2005;127:275–83.CrossRefPubMed Swigris J, Kuschner W, Kelsey J, Gould M. Idiopathic Pulmonary Fibrosis: Challenges and Opportunities for the Clinician and Investigator. Chest. 2005;127:275–83.CrossRefPubMed
18.
go back to reference Schoenheit G, Becattelli I, Cohen A. Living with Idiopathic Pulmonary Fibrosis: An in-Depth Qualitative Survey of European Patients. Chron Respir Dis. 2011;8(4):225–31.CrossRefPubMed Schoenheit G, Becattelli I, Cohen A. Living with Idiopathic Pulmonary Fibrosis: An in-Depth Qualitative Survey of European Patients. Chron Respir Dis. 2011;8(4):225–31.CrossRefPubMed
19.
go back to reference Bajwah S, Higginson I, Ross J, Wells A, Birring S, Riley J, et al. The Palliative Care Needs for Fibrotic Interstitial Lung Disease: A Qualitative Study of Patients, Informal Caregivers and Health Professionals. Palliat Med. 2013;27:869–76.CrossRefPubMed Bajwah S, Higginson I, Ross J, Wells A, Birring S, Riley J, et al. The Palliative Care Needs for Fibrotic Interstitial Lung Disease: A Qualitative Study of Patients, Informal Caregivers and Health Professionals. Palliat Med. 2013;27:869–76.CrossRefPubMed
20.
go back to reference Tong A, Sainsbury P, Craig J. Consolidated Criteria for Reporting Qualitative Research (Coreq): A 32-Item Checklist for Interviews and Focus Groups. International J Qual Health Care. 2007;19(6):349–57.CrossRef Tong A, Sainsbury P, Craig J. Consolidated Criteria for Reporting Qualitative Research (Coreq): A 32-Item Checklist for Interviews and Focus Groups. International J Qual Health Care. 2007;19(6):349–57.CrossRef
21.
go back to reference Collard H, Moore B, Flaherty K, Brown K, Kaner R, King T, et al. Acute Exacerbations of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2007;176:636–43.PubMedCentralCrossRefPubMed Collard H, Moore B, Flaherty K, Brown K, Kaner R, King T, et al. Acute Exacerbations of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2007;176:636–43.PubMedCentralCrossRefPubMed
22.
go back to reference Waller A, Girgis A, Johnson C, Lecathelenais C, Sibbritt D, Seldon M, et al. Implications of a Needs Assessment Intervention for People with Progressive Cancer: Impact on Clinical Assessment. Response and Service Utilisation Psychooncology. 2012;21(5):550–7.PubMed Waller A, Girgis A, Johnson C, Lecathelenais C, Sibbritt D, Seldon M, et al. Implications of a Needs Assessment Intervention for People with Progressive Cancer: Impact on Clinical Assessment. Response and Service Utilisation Psychooncology. 2012;21(5):550–7.PubMed
26.
go back to reference Epiphaniou E, Shipman C, Harding R, Mason B, Murray S, Higginson I, et al. Coordination of End-of-Life Care for Patients with Lung Cancer and Those with Advanced COPD Are There Transferable Lessons? A Longitudinal Qualitative Study. Prim Care Respir J. 2014;23:46–51.CrossRefPubMed Epiphaniou E, Shipman C, Harding R, Mason B, Murray S, Higginson I, et al. Coordination of End-of-Life Care for Patients with Lung Cancer and Those with Advanced COPD Are There Transferable Lessons? A Longitudinal Qualitative Study. Prim Care Respir J. 2014;23:46–51.CrossRefPubMed
27.
go back to reference Belkin A, Swigris J. Patient Expectations and Experiences in Idiopathic Pulmonary Fibrosis: Implications of Patient Surveys for Improved Care. Expert Rev Respir Med. 2014;8(2):173–8.CrossRefPubMed Belkin A, Swigris J. Patient Expectations and Experiences in Idiopathic Pulmonary Fibrosis: Implications of Patient Surveys for Improved Care. Expert Rev Respir Med. 2014;8(2):173–8.CrossRefPubMed
Metadata
Title
The care needs of patients with idiopathic pulmonary fibrosis and their carers (CaNoPy): results of a qualitative study
Authors
Cathy Sampson
Ben Hope Gill
Nicholas Kim Harrison
Annmarie Nelson
Anthony Byrne
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2015
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-015-0145-5

Other articles of this Issue 1/2015

BMC Pulmonary Medicine 1/2015 Go to the issue